Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-02-28
1997-02-04
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514573, 560121, 562503, C07C40500, A61K 31557
Patent
active
055998372
ABSTRACT:
The present invention relates to a 15-deoxyprostaglandin derivative of the formula (I): ##STR1## in which ##STR2## is a 5 membered ring which is selected from a group consisting of ##STR3## R.sup.1 is hydrogen or lower alkyl; R.sup.2 is C.sub.6 -C.sub.12 alkyl, C.sub.6 -C.sub.12 alkenyl or C.sub.6 -C.sub.12 alkadienyl;
provided that the compound of the following formula is excluded: ##STR4## wherein R' is hydrogen or methyl; or pharmaceutically acceptable salts thereof. The invention also relates to a pharmaceutical formulation comprising a 15-deoxyprostaglandin derivative as an active ingredient, which is useful as an intraocular pressure reducing agent.
REFERENCES:
patent: 3290226 (1966-12-01), Beal
patent: 3847962 (1974-11-01), Patterson et al.
patent: 3872139 (1975-03-01), Patterson et al.
patent: 4599353 (1986-07-01), Bito
Hamon et al., Tetrahedron Letters, No. 50, pp. 4481-4482 (1975).
Gorman et al., Chemical Abstracts 87(25): 194421c.
Gorman et al., Proc. Natl. Acad. Sci., vol. 74, No. 9, pp. 4007-4011, Sep. 1977, "Inhibition of Human Platelet Thromboxane Synthetase by 9, 11-axoprosta-5, 13-dienoic Acid".
Corey et al., Journal of the American Chemical Society, 93:6, Mar. 24, 1971, "Stereospecific Total Synthesis of Prostaglandins E.sub.3 and E.sub.3 .alpha.".
Goh et al., Japanese Journal of Ophthalmology, vol. 32, pp. 471-480, 1988, "Effects of Prostaglandin D.sub.2 and its Analogues on Intraocular Pressure in Rabbits".
Granstrom et al., Prostaglandins and Related Substances, pp. 7-13, IRL Press Limited, "Metabolism of Prostaglandins and Lipoxygenase Products: Relevance for Eicosanoid Assay".
Ohuchida et al., TET, vol. 39, No. 24-P, p. 4263, "Synthesis of Thromboxane A.sub.2 Analogs-2".
Prostaglandins: An Introduction to Their Biochemistry, Physiology and Pharmacology, pp. 23-27, 1976, Elsevier/North-Holland Biomedical Press, "Catabolism of Prostaglandins".
Ohuchida et al., J. Am. Chem. Soc., 1981, 103, pp. 4597-4599, "Synthesis of Trhomboxane A.sub.2 Analogues: DL-9, 11:11,12-Dideoxa-9,11:11,12-diepithiothromboxane A.sub.2".
Collins, Journal of Medicinal Chemistry, vol. 29, No. 4, Apr. 1986, "Development and Therapeutic Role of Synthetic Prostaglandins in Peptic Ulcer Disease".
Goh Yasumasa
Kawada Kenji
Kishi Morio
Takahashi Kimio
Gerstl Robert
Shionogi & Co. Ltd.
LandOfFree
Treatment for hypertension or glaucoma in eyes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for hypertension or glaucoma in eyes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for hypertension or glaucoma in eyes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-679041